ZCZL Industrial Technology Group (00564) plans to establish ZCZL Industrial Technology Group (Zhengzhou) Industrial Investment Partnership Enterprise specifically engaged in overseas investment business.

ZCZL Industrial Technology Group (00564) announced that in order to implement the company's strategy of dual-wheel development driven by industry and investment, and to strengthen the capital operation business system integrating equity investment, entrepreneurship incubation, industrial ecosystem construction, and mergers and acquisitions, the company plans to establish a wholly-owned subsidiary, Zhengzhou ZCZL Industrial Technology Group Future Investment Management Co., Ltd., with a capital of RMB 10 million, using its own funds. The company will act as a limited partner with a capital contribution of RMB 299 million, while Zhengzhou ZCZL Industrial Technology Group Future Investment Management Co., Ltd., will act as a general partner with a capital contribution of RMB 1 million to establish ZCZL Industrial Technology Group (Zhengzhou) Industrial Investment Partnership Enterprise (Limited Partnership) (tentative name, subject to the approval and registration with the market supervision and administration authority), dedicated to foreign investment business. In line with the company's development strategy for the next 5-10 years, on the basis of internal development, the ShenZhen New Industries Biomedical Engineering investment platform will focus on foreign investment in the future, promoting the company's industrial upgrading, finding and cultivating a "second growth curve", and achieving sustainable high-quality growth for the listed company. In alignment with the strategic orientation of the national "15th Five-Year Plan" and the company's own development strategy, the ShenZhen New Industries Biomedical Engineering investment platform will focus on the following directions for investment: First, focusing on key enterprises in the upstream and downstream of the company's existing main industry chain, supporting major technological equipment research and development, and improving resilience and global competitiveness through industrial chain collaboration; second, deploying strategic emerging industries, focusing on new energy, new materials, semiconductors, aerospace, Siasun Robot & Automation, and intelligent equipment fields to resonate with the positioning of "building emerging pillar industries" in the 15th Five-Year Plan; third, deepening internal innovation ecosystem construction by establishing special investment platforms to support internal incubation of enterprises and innovation and entrepreneurship of scientific and technological talents, accelerating the industrialization of scientific and technological innovation achievements, and promoting the full chain loop of "laboratory technology engineering implementation commercialization", forming an innovative dual-wheel drive of internal and external synergy. This investment mainly focuses on the combination investment of companies related to the company's main industry chain and strategic emerging industries. By investing in companies in these areas, the company can fully utilize its own funds, rely on the investment management professional capabilities and resource integration advantages of the ShenZhen New Industries Biomedical Engineering investment platform, further improve the company's industrial chain layout, reserve and cultivate new strategic projects for the company, seize timely merger and acquisition opportunities in the industry, achieve industrial synergy effects, find new growth curves for the company in the future, and enhance the company's overall competitiveness. This investment will help the company implement its long-term development strategy, explore the path of investment in ShenZhen New Industries Biomedical Engineering, enhance its foresight capabilities in frontier areas, empower the search for new business paths, and lay a foundation for the company's growth in 5-10 years.